Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O14672 | Disintegrin and metalloproteinase domain-containing protein 10 | ||
O14763 | Tumor necrosis factor receptor superfamily member 10B | ||
O14773 | Tripeptidyl-peptidase 1 | ||
O14786 | Neuropilin-1 | ||
O14791 | Apolipoprotein L1 | ||
O14967 | Calmegin | ||
O15031 | Plexin-B2 | ||
O15072 | A disintegrin and metalloproteinase with thrombospondin motifs 3 | ||
O15230 | Laminin subunit alpha-5 | ||
O15232 | Matrilin-3 |
Pathway Name | Organism |
---|---|
Lectin pathway of complement activation | Sus scrofa |
Lectin pathway of complement activation | Canis familiaris |
Lectin pathway of complement activation | Xenopus tropicalis |
Lectin pathway of complement activation | Rattus norvegicus |
Lectin pathway of complement activation | Homo sapiens |
Lectin pathway of complement activation | Mus musculus |
Lectin pathway of complement activation | Gallus gallus |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
29673805 | Effect of N-acetylgalactosamine ligand valency on targeting dendrimers to hepatic cancer cells | Kuruvilla SP | 2018 Jul 10 |
|
29374258 | Identification of a Golgi GPI-N-acetylgalactosamine transferase with tandem transmembrane regions in the catalytic domain | Hirata T | 2018 Jan 26 |
|
29277975 | Perineuronal nets in subcortical auditory nuclei of four rodent species with differing hearing ranges | Beebe NL | 2018 Jan 17 |
|
29303968 | Functional Expression and Characterization of the Recombinant N-Acetyl-Glucosamine/N-Acetyl-Galactosamine-Specific Marine Algal Lectin BPL3 | Hwang HJ | 2018 Jan 05 |
|
28988716 | Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression | Willoughby JLS | 2018 Jan 03 |
|
29097258 | Site-specific O -glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane | Lackman JJ | 2018 Jan |
|
29174389 | Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a)Rx and IONIS-APO(a)-LRx antisense oligonucleotide clinical trials | Marcovina SM | 2018 Jan |
|
29459660 | Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity | Janas MM | 2018 Feb 19 |
|
29300154 | Acinetobacter baumannii isolate BAL_212 from Vietnam produces the K57 capsular polysaccharide containing a rarely occurring amino sugar N-acetylviosamine | Kenyon JJ | 2018 Feb 01 |
|
29217428 | Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis | Saentaweesuk W | 2018 Feb |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025